Literature DB >> 10766901

Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease.

H Sawada1, F Udaka, Y Izumi, K Nishinaka, H Kawakami, S Nakamura, M Kameyama.   

Abstract

Cerebral white matter lesions, such as leukoaraiosis, may be a result of damage from cerebral ischaemia, and may also be associated with the degenerative process in Alzheimer's disease. The apolipoprotein epsilon4 (apoepsilon4) genotype is a genetic risk factor for both Alzheimer's disease and ischaemic brain damage through acceleration of atherosclerosis. The aim was to determine whether apoepsilon4 may be related to the formation of cerebral white matter lesions in Alzheimer's disease. The association of apoE genotype, sex, age, and the presence of several vascular risk factors, with the presence of white matter lesions in 55 patients clinically diagnosed with Alzheimer's disease was investigated. The cerebral white matter lesions were identified by T2 weighted MRI and classified on a 4 grade scale from no lesion to diffuse lesion. The odds ratio (OR) of the factors mentioned above to the presence of white matter lesions was determined and tested by Fisher's exact test. The association of the lesion grades with these factors was analysed by non-parametric tests. The apoE 4 genotype was strongly associated with Alzheimer's disease (p=0.0001), but not associated with the presence or the degree of cerebral white matter lesions in Alzheimer's disease (OR=1.09, p>0.99). Aging (>70 years old) was a significant risk factor for white matter lesions (OR=7.2, p=0.0006) and age was significantly correlated with the lesion (p=0.0075). The OR of female sex to the lesion grades was 2.89 (p=0.084) and the lesion grade of female sex was significantly higher than that of the male sex (p=0.047). Other vascular risk factors were not significantly associated with the presence of white matter lesions. These findings suggest that there is a sex difference in white matter pathology in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766901      PMCID: PMC1736920          DOI: 10.1136/jnnp.68.5.653

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.

Authors:  J Tian; J Shi; K Bailey; C L Lendon; S M Pickering-Brown; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 2.  Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis).

Authors:  Zoltán Szolnoki
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

3.  Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.

Authors:  Santiago Rojas; Anna Brugulat-Serrat; Nuria Bargalló; Carolina Minguillón; Alan Tucholka; Carles Falcon; Andreia Carvalho; Sebastian Morán; Manel Esteller; Nina Gramunt; Karine Fauria; Jordi Camí; José L Molinuevo; Juan D Gispert
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-11       Impact factor: 6.200

4.  Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease.

Authors:  Changsheng Wang; Glenn T Stebbins; David A Medina; Raj C Shah; Roland Bammer; Michael E Moseley; Leyla deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2010-04-01       Impact factor: 4.673

Review 5.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

Review 6.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

7.  Asymmetry, sex differences and age-related changes in the white matter in the healthy elderly: a tract-based study.

Authors:  Soichiro Kitamura; Masayuki Morikawa; Kuniaki Kiuchi; Toshiaki Taoka; Masami Fukusumi; Kimihiko Kichikawa; Toshifumi Kishimoto
Journal:  BMC Res Notes       Date:  2011-10-04

Review 8.  Vascular pathology in the aged human brain.

Authors:  Lea Tenenholz Grinberg; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2010-02-14       Impact factor: 17.088

9.  A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interactions behind vascular white matter demyelinization.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Ferenc Somogyvari
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 10.  Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice.

Authors:  Caleb E Finch; Sara Shams
Journal:  Trends Neurosci       Date:  2016-08-18       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.